A Study of LY4167586 in Participants With Obesity or Overweight Who Are Otherwise Healthy

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The purpose of this study is to look at how safe and well-tolerated LY4167586 is in participants with obesity or overweight who are otherwise healthy. Blood tests will be performed to check how much LY4167586 gets into the bloodstream and how long it takes the body to eliminate it following a single administration. Participation in the study will last approximately 7 months.
Epistemonikos ID: 994e3056812c1ca5ffbfb7af702e6abb8647f059
First added on: Nov 07, 2025